Shares of chemical maker, American Vanguard
(AVD - Free Report
) touched a fresh 52-week high of $21 on Sep 5, before pulling back to eventually close the day at $20.05.
American Vanguard has a market cap of roughly $597.2 million and average volume of shares traded in the last three months is around 91.9K. The company has an expected long-term earnings per share growth of around 15%.
American Vanguard’s shares have moved up 30.2% over the last year, outperforming the industry
’s gain of 1.4%.
American Vanguard’s profits jumped around 33% year over year in second-quarter 2017, helped by its cost-control initiatives. Sales also rose in the quarter, partly driven by strong demand for cotton products.
American Vanguard announced that its outlook for the remainder of 2017 is positive. The company noted that significant increase cotton acreage in the United States is likely to provide additional sales of Bidrin foliar insecticide and Folex harvest defoliant in the second half of 2017. American Vanguard also sees modest international growth and a rebound in its soil fumigant business.
Moreover, the company expects continued demand for its Dibrom mosquito adulticide. The company remains focused on managing working capital and operational costs and investing in technology innovation for future growth.
American Vanguard’s fully-owned unit AMVAC Mexico Srl, last month, completed the purchase of specific herbicide and fungicide products sold in Mexico from Syngenta AG. The addition of these products complements and strengthens American Vanguard’s herbicide and fungicide offerings.
American Vanguard Corporation Price and Consensus